Advertisement

Biological vs. Psychological Treatments of Anxiety Disorders

  • Walton T. Roth
Chapter
Part of the Applied Clinical Psychology book series (NSSB)

Abstract

In my other chapter in this book (Biological vs. Psychological Perspectives on Anxiety Disorder) I presented a Table 1 listing some proposed etiologies of anxiety disorders and corresponding treatments. It would be wrong to infer from this table that the postulated causes were discovered first and the treatments followed as logical deductions. In many cases, a cause was inferred from the presumed mechanism of action of some treatment believed to be effective against anxiety. Treatments of mental disorders have always seemed more rooted in reality than theories of mental disorders. It is instructive, therefore, to examine outcome studies of purportedly successful biological and psychological treatments of anxiety disorders in order to determine how solid the factual bases of those inferences really are.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agras, W.S., Teich, M.J., Taylor, C.B., Roth, W.T., and Brouillard, M.E. (1990). Imipramine and exposure therapy in agoraphobia: Untangling the actions and interactions. Submitted for publication.Google Scholar
  2. Ballenger, J.C., Burrows, G.D., DuPont, R.L., Lesser, I.M., Noyes, R, Jr., Pecknold, J.C, Rifkin, A., and Swinson, R.P. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I. Efficacy in short-term treatment. Archives of General Psychiatry, 45, 413–422.PubMedCrossRefGoogle Scholar
  3. Clark, D.B., Taylor, C.B., Roth, W.T., and Agras, W.S. (1990) Surreptitious antianxiety medication use in a panic disorder study. American Journal of Psychiatry, 147, 507–509.PubMedGoogle Scholar
  4. Cohen, S.D., Monteiro, W., and Marks, I.M. (1984). Two-year follow-up of agoraphobics after exposure and imipramine. British Journal of Psychiatry, 144, 276–281.PubMedCrossRefGoogle Scholar
  5. Craske, M.G., Sanderson, W.C., and Barlow, D.H. (1987). How do desynchronous response systems relate to the treatment of agoraphobia: A follow-up evaluation. Behaviour Research and Therapy, 25, 117–122.PubMedCrossRefGoogle Scholar
  6. Dilsaver, S.C., and Coffman, J.A. (1989). Cholinergic hypothesis of depression: A reappraisal. Journal of Clinical Psychopharmacology, 9, 173–179.PubMedCrossRefGoogle Scholar
  7. Fiegenbaum, W. (1988). Long-term efficacy of ungraded versus graded massed exposure in agoraphobics. In I. Hand and H.-U. Wittchen (Eds.), Panic and Phobias 2. Treatments and Variables affecting Course and Outcome (pp. 83–88). Berlin: Springer-Verlag.Google Scholar
  8. Fisher, S., and Greenberg, R.P. (1989). A second opinion: Rethinking the claims of biological psychiatry. In S. Fisher and R.P. Greenberg (Eds.), The Limits of Biological Treatments for Psychological Distress. Comparisons with Psychotherapy and Placebo (pp. 309–336). Hillsdale, NJ: Erlbaum.Google Scholar
  9. Frank, J.D. (1961). Persuasion and Healing. A Comparative Study of Psychotherapy. Baltimore: Johns Hopkins Press.Google Scholar
  10. Greenberg, R.P, and Fisher, S. (1989). Examining antidepressant effectiveness: Findings, ambiguities, and some vexing puzzles. In S. Fisher and R.P. Greenberg (Eds.), The Limits of Biological Treatments for Psychological Distress. Comparisons with Psychotherapy and Placebo (pp. 1–37). Hillsdale, NJ: Erlbaum.Google Scholar
  11. Klein, D.F. (1980) Anxiety reconceptualized. Comprehensive Psychiatry, 21, 411–427.PubMedCrossRefGoogle Scholar
  12. Klein, D.F., Zitrin, C.M., Woerner, M.G., Ross, D.C. (1983). Treatment of Phobias. II. Behavior therapy and supportive psychotherapy: Are there any specific ingredients? Archives of General Psychiatry, 40, 139–145.PubMedCrossRefGoogle Scholar
  13. Klerman, G.I., Ballenger, J.C., Burrows, G.D., DuPont, R.L., Noyes, R., Jr., Pecknold, J.C., Rofkin, A., Rubin, R.T., and Swinson, R.P. (1989) In reply. [to Marks et al. (1989)]. Archives of General Psychiatry, 46, 670–672.CrossRefGoogle Scholar
  14. Margraf, J. (1989). Beiträge zur Diagnostik, Theorie und Therapie des Paniksyndroms. Habilitationsschrift, Fachbereich Psychologie der Philipps-Universität Marburg. Submitted 1989.Google Scholar
  15. Margraf, J., Ehlers, A., and Roth, W.T. (1986a). Panic attacks: Theoretical models ar 1 empirical evidence. In I. Hand and H.-U. Wittchen (Eds.), Panic and Phobias (pp. 31–43), Berlin: Springerf.CrossRefGoogle Scholar
  16. Margraf, J., Ehlers, A., and Roth, W.T. (1986b). Biological models of panic disorder and agoraphobia: A review. Behaviour Research and Therapy, 24, 553–567.PubMedCrossRefGoogle Scholar
  17. Margraf, J., Ehlers, A., and Roth, W.T. (1986c) Sodium lactate infusions and panic attacks: A review and critique. Psychosomatic Medicine, 48, 23–51.PubMedGoogle Scholar
  18. Margraf, J., Ehlers, A., and Roth, W.T. (1988) Mitral valve prolapse and panic disorder: A review of their relationship. Psychosomatic Medicine, 50, 93–113.PubMedGoogle Scholar
  19. Marks, I.M. (1987). Fears, Phobias, and Rituals. Panic, Anxiety, and Their Disorders. Oxford: Oxford University Press.Google Scholar
  20. Marks, I.M., De Albuquerque, A., Cottraux, J., Gentil, V., Greist, J., Hand, L, Liberman, R.L., Relvas, J.S., Tobena, A., Tyrer, P, and Wittchen, H.-U. (1989). The ‘efficacy’ of alprazolam in panic disorder and agoraphobia: A critique of recent reports. Letter to the Editor. Archives of General Psychiatry, 46, 668–670.PubMedCrossRefGoogle Scholar
  21. Marks, I.M., Gray, S., Cohen, D., Hill, R., Mawson, D., Ramm, E., and Stem, R. (1983). Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Archives of General Psychiatry, 40, 153–162.PubMedCrossRefGoogle Scholar
  22. Mavissakalian, M. (1988). The mutually potentiating effects of imipramine and exposure in agoraphobia. In I. Hand, and H.-U. Wittchen. Panic and Phobias 2. Treatments and Variables affecting Course and Outcome (pp. 36–43). Berlin: Springer-Verlag.Google Scholar
  23. Mavissakalian, M., and Michelson, L. (1982). Agoraphobia: Behavioral and pharmacological treatments, preliminary outcome, and process findings. Psychopharmacology Bulletin, 18, 91–103.PubMedGoogle Scholar
  24. Mavissakalian, M., and Michelson, L. (1986). Relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. Journal of Clinical Psychiatry, 143, 1106–1112.Google Scholar
  25. Mavissakalian, M., Michelson, L., and Dealy, R.S. (1983). Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice. British Journal of Psychiatry, 143, 348–355.PubMedCrossRefGoogle Scholar
  26. Mellman, T.A., and Uhde, T.W. (1989). Electroencephalographic sleep in panic disorder. Archives of General Psychiatry, 46, 178–184.PubMedCrossRefGoogle Scholar
  27. Overton, D.A. (1966). State-dependent learning produced by depressant and atropine-like drugs. Psychopharmacologia, 23, 373–385.Google Scholar
  28. Pecknold, J.C., Swinson, R.P., Kuch, K., and Lewis, C.P. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. HI. Discontinuation effects. Archives of General Psychiatry, 45, 429–436.PubMedCrossRefGoogle Scholar
  29. Rachman, S., Craske, M., Tallman, K., and Solyom, C. (1986). Does escape behavior strengthen agoraphobic avoidance? A replication. Behavior Therapy, 17, 366–384.CrossRefGoogle Scholar
  30. Telch, M.J., Agras, W.S., Taylor, C.B., Roth, W.T., and Gallen, C.C (1985). Combined pharmacological and behavioral treatment for agoraphobia. Behaviour Research and Therapy, 25, 325–335.CrossRefGoogle Scholar
  31. Vermilyea, J.A., Boice, R., and Barlow, D.H. (1984). Rachman and Hodgson (1974) a decade later: How do desynchronous response systems relate to the treatment of agoraphobia? Behaviour Research and Therapy, 22, 615–621.PubMedCrossRefGoogle Scholar
  32. Weissman, M.M., Klerman, G.L., Markowitz, J.S., and Ouellette, R. (1989). Suicidal ideation and suicide attempts in panic disorder and attacks. New England Journal of Medicine, 321, 1209–1214.PubMedCrossRefGoogle Scholar
  33. Zitrin, C.M., Klein, D.F., and Woemer, M.G. (1980). Treatment of agoraphobia with group exposure in vivo and Imipramine. Archives of General Psychiatry, 37, 63–72.PubMedCrossRefGoogle Scholar
  34. Zitrin, C.M., Klein, D.G., Woemer, M.G., and Ross, D.C. (1983). Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo. Archives of General Psychiatry, 40, 125–138.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Walton T. Roth
    • 1
  1. 1.Psychiatry (116A3)VA Medical CenterPalo AltoUSA

Personalised recommendations